
Nova Mentis (OTC: NMLSF) Psilocybin Manufacturer Receives Approved Health Canada Importation Permit
Phase 2A Microdose Clinical Study Capsules to be Manufactured VANCOUVER, BC, May 4, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics […]